Related Experiment Videos
[Vaginal candidiasis--treatment protocols using miconazole and fluconazole]
1SHATOG Maichin dom, Medical University, Sofia.
Akusherstvo I Ginekologiia
|November 19, 2003
Summary
Vaginal yeast infections, often caused by Candida species, are increasingly common. While local treatments are effective for acute cases, chronic infections may require prolonged oral or local therapy, with fluconazole being a preferred oral option due to its safety profile.
Area of Science:
- Mycology
- Epidemiology
- Infectious Diseases
Context:
- Fungal infections, particularly vaginal candidiasis, show a rising incidence globally.
- Candida species are responsible for 45% of vaginal infections, affecting a significant portion of women.
- Asymptomatic colonization with Candida is common, complicating diagnosis and treatment.
Purpose:
- To review the epidemiology, diagnosis, and treatment of vaginal candidiasis.
- To highlight the challenges in managing recurrent and chronic forms of the infection.
- To discuss current therapeutic strategies, including local and systemic antifungal agents.
Summary:
- Vaginal candidiasis is a prevalent condition, with Candida species being the primary causative agents.
- Diagnosis involves macroscopic and microscopic examination, culture, and sometimes Pap tests.
- Treatment principles include eliminating predisposing factors and antifungal therapy, with local treatments for acute infections and prolonged systemic or local therapy for chronic cases.
Impact:
- Effective management strategies are crucial for improving patient outcomes and reducing recurrence rates.
- Understanding transmission routes and risk factors can aid in prevention.
- Fluconazole emerges as a well-tolerated oral option for continuous treatment of persistent vaginal yeast infections.